Published in Cancer Weekly, February 11th, 2003
Because the impact of antiangiogenesis agents on the vessels they target has not been thoroughly explored, researchers at the University of Pennsylvania in Philadelphia undertook a study to better understand how antivascular agents affect vessels during their development.
"Hypothesizing that the response of vessels to therapy is influenced by their stage of maturation, we studied vascular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.